Article
Impact of age, gender and CYP2C9/2C19 genotypes on dose-adjusted steady-state serum concentrations of valproic acid-a large-scale study based on naturalistic therapeutic drug monitoring data.
European journal of clinical pharmacology - 1 Sept 2016
Smith R L, Haslemo T, Refsum H, Molden E
Abstract excerpt
PURPOSE: Valproic acid (VPA) has an extensive interindividual pharmacokinetic variability. Published data regarding the impact of gender, age, and CYP2C9/2C19 genetics on VPA variability are conflicting, and the purpose of present study is to clarify the effect of these factors on dose-adjusted steady-state serum VPA concentration (C:D ratio) in a large, naturalistic patient material. METHODS: In patients who had...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.